0 Комментарии
0 Поделились
363 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Biosimilars Create New Growth Opportunities in Rheumatoid Arthritis TherapeuticsThe growing emphasis on early diagnosis and effective long-term management of autoimmune diseases is supporting demand for rheumatoid arthritis drugs. Rheumatoid arthritis is a chronic inflammatory condition that primarily affects the joints and can cause pain, swelling, stiffness, reduced mobility, and joint damage. Treatment typically involves disease-modifying antirheumatic drugs (DMARDs),...0 Комментарии 0 Поделились 169 Просмотры 0 предпросмотр
-
Rheumatoid Arthritis Therapeutics Market Sees New Opportunities in Biologic TreatmentsNovember 2, 2026 — The global rheumatoid arthritis therapeutics market is estimated at USD 28.22 billion in 2026 and is projected to reach USD 45.53 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.9% during the forecast period, according to Fact.MR. The market was valued at approximately USD 26.9 billion in 2025. Growing adoption of advanced biologic treatments,...0 Комментарии 0 Поделились 6 Просмотры 0 предпросмотр